FenixOro Gold (FDVXF)
OTHER OTC:FDVXF

FenixOro Gold (FDVXF) Income Statement

4 Followers

FenixOro Gold Income Statement

Last quarter (Q3 2023), FenixOro Gold's total revenue was C$0.00, a decrease of ― from the same quarter last year. In Q3, FenixOro Gold's net income was C$-1.67M. See FenixOro Gold’s key income statements, including revenue, expenses, profit, and income.
Income Statement
TTM
Feb 22Feb 21Feb 20Feb 19Feb 18
Total Revenue
--C$ -464.58KC$ 0.00C$ 0.00C$ 0.00
Cost of Revenue
C$ 3.65KC$ 5.35KC$ 6.28KC$ 0.00--
Gross Profit
C$ -3.65KC$ -5.35KC$ -6.28KC$ 0.00--
Operating Expense
C$ 4.99MC$ 4.35MC$ 4.59MC$ 1.44MC$ 523.29KC$ 193.89K
Operating Income
C$ -5.00MC$ -4.35MC$ -4.60MC$ -1.44MC$ -523.29KC$ -193.89K
Net Non Operating Interest Income Expense
------
Other Income Expense
C$ 97.75KC$ 92.77KC$ 91.09KC$ -559.87KC$ -1.65KC$ -1.75K
Pretax Income
C$ -4.90MC$ -4.26MC$ -4.51MC$ -2.00MC$ -524.94KC$ -195.65K
Tax Provision
------
Earnings From Equity Interest Net Of Tax
------
Net Income Common Stockholders
C$ -4.90MC$ -4.26MC$ -4.51MC$ -2.00MC$ -524.94KC$ -195.65K
Basic EPS
C$ -0.06C$ -0.05C$ -0.07C$ -0.07C$ -0.03C$ -0.01
Diluted EPS
C$ -0.06C$ -0.05C$ -0.07C$ -0.07C$ -0.03C$ -0.01
Basic Average Shares
C$ 377.17MC$ 85.18MC$ 64.28MC$ 26.70MC$ 14.94MC$ 16.42M
Diluted Average Shares
C$ 377.17MC$ 85.18MC$ 64.28MC$ 26.70MC$ 14.94MC$ 16.42M
Dividend Per Share
------
Total Operating Income As Reported
------
Reported Normalized Basic E P S
------
Reported Normalized Diluted E P S
------
Rent Expense Supplemental
------
Total Expenses
C$ 4.41M-C$ -4.60MC$ 1.44MC$ 523.29KC$ 193.89K
Interest Expense
------
Net Income From Continuing And Discontinued Operation
C$ -4.90MC$ -4.26MC$ -4.51MC$ -2.00MC$ -524.94KC$ -195.65K
Normalized Income
C$ -4.84MC$ -3.13MC$ -3.31MC$ -1.44MC$ -523.29KC$ -193.89K
EBIT
C$ -5.00MC$ -4.26MC$ -4.51MC$ -1.44MC$ -523.29KC$ -193.89K
EBITDA
C$ -4.99MC$ -4.25MC$ -4.50MC$ -1.44MC$ -523.29KC$ -193.89K
Currency in CAD

FenixOro Gold Earnings and Revenue History

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis